Total Temporomandibular Joint Replacement
On this page
Direct answer
When the temporomandibular joint is destroyed beyond salvage — end-stage degenerative or inflammatory arthritis, recurrent ankylosis, condylar resorption, or failure of previous reconstruction — an alloplastic total joint replacement replaces it with a cobalt-chromium mandibular condylar component articulating against an ultra-high-molecular-weight polyethylene fossa. Surgery is a gap arthroplasty plus ipsilateral coronoidectomy to restore jaw excursion, meticulous removal of ankylotic bone, and interposition of autogenous fat around the prosthesis to deter heterotopic bone and re-ankylosis. Custom prostheses are planned on stereolithic models from the patient's own CT; stock systems suit common anatomies. Growing children are the exclusion — for them the costochondral graft, with all its unpredictability, remains standard.
What you must remember
- Indications list for theory answers: ankylosis (especially recurrent), end-stage degenerative joint disease with condylar loss, rheumatoid and juvenile idiopathic arthritis, idiopathic condylar resorption, post-traumatic condylar destruction, failure of alloplastic or autogenous reconstruction, and tumour resection defects in selected adults.
- Contraindications: active infection anywhere in the operative field, uncontrolled systemic disease, documented allergy to cobalt-chromium, titanium or polyethylene, and — relative — severe uncontrolled parafunction; a growing jaw excludes alloplasty.
- Materials: mandibular component of cobalt-chromium alloy; fossa of ultra-high-molecular-weight polyethylene; titanium alloy interfaces for osseointegration — quotable in vivas.
- Custom versus stock: custom-fitted systems built on a stereolithic CT model restore anatomy precisely at higher cost; stock prostheses are off-the-shelf and suit standard anatomies — the cost difference matters enormously in Indian practice.
- The operation's three acts: wide gap arthroplasty with excision of ankylotic mass to native glenoid, ipsilateral coronoidectomy (with contralateral if opening stays under target), then component seating with autogenous abdominal fat packed around the joint to prevent heterotopic bone.
- Function targets: intraoperative interincisal opening of roughly 35 millimetres or more is the usual end point; postoperative physiotherapy maintains it.
- Outcomes: large series report durable pain relief and opening gains with survivorship above ninety per cent at long follow-up; Indian experience is growing in specialist centres.
- The child exception: costochondral graft in the growing patient — its growth is unpredictable (excess, deficiency, fracture, ankylosis), which is precisely why alloplasty dominates adult practice.
From workup to a seated prosthesis
Walk a 24-year-old with two failed releases of bilateral ankylosis through the pipeline. She opens 8 millimetres, has a retruded chin and obstructive symptoms at night. Step one is three-dimensional CT mapping the ankylotic masses against the skull base and the relation of the internal maxillary artery; step two is CT-based custom prosthetic planning with a stereolithic model — the surgeon rehearses osteotomies on the replica. Step three is the staged operation: preauricular and retromandibular or submandibular access, removal of the ankylotic block with constant awareness of the middle cranial fossa above and the internal maxillary artery medially, coronoidectomy on the same side, checking opening until it exceeds about 35 millimetres, then fat graft harvested from the abdomen packed around the articulation before the components seat. Step four, deciding long-term success, is aggressive supervised physiotherapy from within days, because a prosthesis wrapped in scar is a new ankylosis.
The alternative patient, a 45-year-old with rheumatoid destruction and no prior surgery, may do well with a stock system, saving the custom-fabrication cost — a real Indian theatre decision. In both, consent covers facial nerve risk, bleeding and lifelong surveillance of foreign material.
Costs and choices in Indian practice
Alloplastic total joint systems are imported, and a custom prosthesis with the planning model adds several lakh rupees to the hospital bill — the honest reason Indian teaching programmes still teach gap arthroplasty with interpositional temporalis muscle as the default and alloplasty as referral care. Viva examiners expect this layering: know the interpositional ladder (temporalis myofascial flap, dermis, full-thickness skin, cartilage) for the resource-limited setting, and know the alloplastic indications where money is not the constraint. The trap question is the child with ankylosis — the correct answer is gap arthroplasty, coronoidectomy, interposition, and costochondral graft if growth reconstruction is needed, never an alloplastic joint in a growing mandible. Quoting fat grafting against heterotopic bone and the 35-millimetre opening target signals reading of the actual technique.
Frequently asked questions
What are the components of a total TMJ prosthesis?
A cobalt-chromium alloy mandibular condylar component and an ultra-high-molecular-weight polyethylene glenoid fossa, in custom (stereolithic-model) or stock configurations.
Why is ipsilateral coronoidectomy performed with joint replacement?
Fibrosed and enlarged coronoid processes restrict opening even after the joint is replaced; their release is integral to achieving the target interincisal opening of about 35 millimetres.
Why is autogenous fat packed around the prosthesis?
Periprosthetic fat grafting deters heterotopic bone formation and re-ankylosis, a leading late failure mode of alloplastic joint reconstruction.
Which patients are unsuitable for alloplastic TMJ replacement?
Those with active infection, uncontrolled systemic disease, allergy to the implant metals or polyethylene, and growing children, for whom costochondral grafting remains standard.
What are the reported outcomes of total TMJ replacement?
Large published series report substantial pain relief, improved and sustained mouth opening, and implant survivorship above ninety per cent at long-term follow-up.